Fast-responding pain (2-4 weeks) Acute injuries: Recent muscle strains Acute joint inflammation Fresh tendon injuries Expected timeline: Week 1-2: Initial pain reduction (20-30%) Week 2-4: Significant improvement (40-60%) Moderate timeline (4-8 weeks) Subacute and mild chronic pain: Joint pain from arthritis (early stage) Older muscle injuries (months old) Moderate tendinitis Expected timeline: Week 2-4: Initial relief Week 4-8: Noticeable improvement (50-70%) Slow-responding pain (8-16+ weeks) Chronic and severe conditions: Severe arthritis Chronic tendinosis (years old) Nerve pain/neuropathy Fibromyalgia Expected timeline: Week 4-8: Slight improvement Week 8-12: Moderate improvement Week 12-16: Significant relief (40-60%) May need 6+ months for maximum benefit Be patient with chronic pain: Tissue took years to damage Healing takes time Don't give up before 12-16 weeks See our how long do peptides take to work guide

The FDA's staff reviewers had last month said there is little evidence to support the safety and effectiveness of these peptides for their intended uses and flagged a lack of adequate human clinical trials, in contrast to Kennedy's public support
During phase 1, interleukin-1 (IL-1) in the DRG tissue was significantly different in the morphine, 10 g/kg BPC-157, and 20 g/kg BPC-157 groups
The mitochondrial epitranscriptome: the roles of RNA modifications in mitochondrial translation and human disease
References De Flora A, Guida L, Franco L, Zocchi E
AOD-9604 is known for its potential to aid in fat loss and support muscle growth, while BPC-157 peptide is recognized for its regenerative properties and ability to enhance tissue healing